Urist Marshall
Royalty Pharma plc · EVP
Urist Marshall is listed in filings as EVP at Royalty Pharma plc. This profile follows SEC Form 4 activity through Jan 26, 2026, including sale activity. Recent filings connect the profile to Royalty Pharma plc (RPRX). The current snapshot covers public activity from Dec 3, 2025 to Jan 26, 2026. Reported amounts are shown as $727.9K to $714.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $728k18.2k shares | SellDec 1, 2025 | $39.90 | $56.31 | |
| $932k23.3k shares | SellDec 1, 2025 | $39.93 | $56.31 | |
| $714k18.2k shares | SellDec 5, 2025 | $39.15 | $56.31 | |
| $914k23.3k shares | SellDec 5, 2025 | $39.15 | $56.31 | |
| $766k20k shares | SellDec 16, 2025 | $38.32 | $56.31 | |
| $768k20k shares | SellDec 19, 2025 | $38.38 | $56.31 | |
| $786k20k shares | SellDec 26, 2025 | $39.32 | $56.31 | |
| $770k20k shares | SellJan 2, 2026 | $38.48 | $56.31 | |
| $816k20k shares | SellJan 9, 2026 | $40.78 | $56.31 | |
| $790k20k shares | SellJan 16, 2026 | $39.52 | $56.31 |